Early recurrence after surgical resection in patients with pathological stage i non-small cell lung cancer

Thoracic and Cardiovascular Surgeon

Volumn 57, Issue 8, 2009, Pages 472-475

  Kawachi, R ^a   Tsukada, H ^a   Nakazato, Y ^a   Takei, H ^a   Furuyashiki, G ^a   Koshi Ishi, Y ^a   Goya, T ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Adjuvant therapy; Carcinoembryonic antigen; Lung cancer; Recurrence; Survival; Thoracic surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLEURA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR NEOPLASMS;

EID: 72849120233     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0029-1185734     Document Type: Article

References (15)

1. Martini N, Bains M S., Burt M E., Zakowski M F., McCormack P, Rusch V W., Ginsberg R J. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995 109 (1) 120-129
2. Harpole Jr D H., Herndon 2nd J E., Young Jr W G., Wolfe W G., Sabiston Jr D C. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995 76 (5) 787-796
3. Douillard J Y., Rosell R, De Lena M, Carpagnano F, Ramlau R, Gonzáles-Larriba J L., Grodzki T, Pereira J R., Le Groumellec A, Lorusso V, Clary C, Torres A J., Dahabreh J, Souquet P J., Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P. ANITA adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006 7 (9) 719-727
4. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon J P., Vansteenkiste J. International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004 350 (4) 351-360
5. Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M. Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004 350 (17) 1713-1721
6. International Union Against Cancer. Lung tumours. Sobin LH, Wittekind CH TNM classification of malignant tumours. 6th ed. New York Wiley-Liss 2002
7. Travis W D., Colby T V., Corrin B et al. Histological typing of lung and pleural tumors; World Health Organization international histological classification of tumors. Berlin Springer 1999
8. Rubins J B., Dunitz J, Rubins H B., Maddaus M A., Niewoehner D E. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg 1998 116 (3) 412-416
9. Sawabata N, Ohta M, Takeda S, Hirano H, Okumura Y, Asada H, Maeda H. Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. Ann Thorac Surg 2002 74 (1) 174-179
10. Buccheri G, Ferrigno D. Identifying patients at risk of early postoperative recurrence of lung cancer: a new use of the old CEA test. Ann Thorac Surg 2003 75 (3) 973-980
11. Takamochi K, Yoshida J, Nishimura M, Yokose T, Sasaki S, Nishiwaki Y, Suzuki K, Nagai K. Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings. Eur J Cardiothorac Surg 2004 25 (5) 877-883
12. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Ann Thorac Surg 2004 78 (3) 1004-1009
13. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med 1997 156 (1) 320-332
14. Depierre A, Lagrange J L., Theobald S, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Brchot J M., Breton J L., Douillard J Y., Grivaux M, Jacoulet P, Khalil A, Lemari E, Martinet Y, Massard G, Milleron B, Molina T, Moro-Sibilot D, Paesmans M, Pujol J L., Quoix E, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet P J., Spaeth D, Stoebner-Delbarre A, Thiberville L, Touboul E, Vaylet F, Vergnon J M., Westeel V, FNCLCC. Summary report of the standards, options and recommendations for the management of patients with non-small-cell lung carcinoma (2000). Br J Cancer 2003 89 (Suppl.1) S35-S49 (Pubitemid 37076148)
15. Silvestri G A., Gould M K., Margolis M L., Tanoue L T., McCrory D, Toloza E, Detterbeck F. American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2ndedition). Chest 2007 132 (Suppl.3) 178S-201S (Pubitemid 47502807)